localis

Describe a service in plain words, or type a CPT/HCPCS code.

Specialty rate rollup

Hematology & Oncology

Office evaluation, infusion and chemotherapy administration, injections, blood counts, and specimen collection.

This is a curated starter set for comparison. It doesn't claim that every specialty bills every code, and it isn't a utilization-weighted average.

At a glance

Q4 2026 compared with the prior available PFS release.

Conversion factor: 0.0% no change

Payable codes

6 / 8

Changed this release

0

Largest increase

None

Largest decrease

None

See the rates where you practice

Enter a ZIP code to apply that Medicare locality’s work, practice-expense, and malpractice adjustments to every row.

Current national rates Copy link

Q4 2026 release

Office (non-facility) and facility professional amounts, GPCI 1.000, before sequestration.

Code and service Status Office (non-facility) Facility
Visits and evaluation
99213 Routine Follow-Up Office Visit Active
$95.19
7.0% increase · Q1 2026
$57.45
9.8% decrease · Q1 2026
99214 Long Follow-Up Office Visit Active
$135.61
8.3% increase · Q1 2026
$84.50
9.9% decrease · Q1 2026
Treatment and ongoing management
96365 Intravenous Therapeutic Infusion Administration Active
$67.14
16.0% increase · Q1 2026
$67.14
16.0% increase · Q1 2026
96372 Therapeutic Injection Administration Active
$15.36
10.4% increase · Q1 2026
$15.36
10.4% increase · Q1 2026
96413 Intravenous Antineoplastic Infusion Administration Active
$133.27
11.7% increase · Q1 2026
$133.27
11.7% increase · Q1 2026
96415 Active
$28.39
11.1% increase · Q1 2026
$28.39
11.1% increase · Q1 2026
Testing and diagnostics
85025 Blood Cell Count With Differential Statutory exclusion
—
—
36415 Blood Draw Statutory exclusion
—
—

Every code links to its contracted-rate (% of Medicare) table and a full RVU breakdown, plus billing-policy context and rate history.

Download this fee schedule (CSV)—free, no account needed.

How often these codes appear in Medicare Copy link

Across Original Medicare nationally in CY2024, the covered codes on this page accounted for the activity below. It counts use by clinicians of every specialty, not just Hematology & Oncology, and CMS publishes it on a different cycle from the fee schedule.

Services

250.2M

Times these codes were billed

Allowed dollars

$18.9B

Across covered Medicare FFS services

Most used in this set

99214

103.7M services

Coverage: 8 of 8 displayed codes. HCPCS Level II and excluded drug codes may not appear in this utilization dataset.

What this specialty actually bills Medicare

Observed CY2024 Medicare fee-for-service billing by Hematology/Oncology clinicians, grouped by CMS rendering-provider specialty. That grouping differs from this page's Hematology & Oncology label, so treat it as context for the curated list above.

Top codes by allowed dollars Share of allowed Allowed
J9271 not in the list above 21.9% $1.5B
99214 7.5% $503.6M
J9144 not in the list above 5.7% $382.0M
J0897 not in the list above 5.6% $375.5M
G6015 not in the list above 5.3% $355.1M
99215 not in the list above 4.4% $296.1M
J9299 not in the list above 3.4% $230.0M
77014 not in the list above 2.8% $189.7M
77427 not in the list above 2.3% $156.3M
77301 not in the list above 2.2% $149.7M
Top codes by services Share of services Services
J1439 not in the list above 11.9% 32.8M
J9271 not in the list above 9.6% 26.6M
Q0138 not in the list above 8.8% 24.2M
J0881 not in the list above 6.5% 18.0M
J0897 not in the list above 5.4% 14.8M
J1453 not in the list above 4.0% 11.1M
J1756 not in the list above 3.0% 8.3M
J9144 not in the list above 2.8% 7.8M
J9299 not in the list above 2.7% 7.6M
J0185 not in the list above 2.6% 7.3M

Localis can price 8% of this cohort's observed services (34% of allowed dollars) under the Q4 2026 release. The rest is clinical lab, drugs, or services paid outside the PFS under other fee schedules, not $0.

Established patient office visits—Office (non-facility)

Visit levels as shares of the 2024 services observed in this family, across 11,752 clinicians.

99211
1%
99212
1%
99213
23%
99214
56%
99215
20%

New patient office visits—Office (non-facility)

Visit levels as shares of the 2024 services observed in this family, across 9,211 clinicians.

99202
0%
99203
6%
99204
36%
99205
58%

CY2024 Medicare fee-for-service only. Codes billed by fewer than 30 observed clinicians in a single setting are not shown, so shares may not total 100%. CMS publishes only a facility vs non-facility split, not exact places of service. Observed use adds context to the curated table above. It doesn't weight or change any rate on this page.

Turn the list into contract math

Analyze a payer offer using these Hematology & Oncology codes

We’ll preload the code set in Contract Check. Add your annual volumes and ZIP to see the volume-weighted percentage of Medicare and annual-dollar difference.

Open in Contract Check

Get notified when Hematology & Oncology rates change

Medicare updates the fee schedule every quarter. We'll email you only when a release moves one of the 8 Hematology & Oncology codes on this page.

Did this answer your question about Hematology & Oncology?

Tell us what you were trying to work out and we'll answer you or build the page that does.

Did this page answer your question?

Source & method Copy link

Amounts are computed from the CMS Medicare Physician Fee Schedule Q4 2026 release, GPCI 1.000, before the ~2% sequestration cut. The grouping by common clinical scenario is our own, not the AMA’s code-family taxonomy, and it’s a curated starter set, not a utilization-weighted specialty mix. A code with no amount is either not separately payable under the PFS or absent from the release. It never means $0.

This page covers PFS-priced professional and administration services. Cancer drug products and clinical laboratory tests use separate Medicare pricing systems, so an unpriced row here is not a $0 Medicare payment.